欧州のGMP細胞治療用消耗品市場の2028年までの予測- 地域別分析、製品別、細胞治療別、プロセス別、最終用途別

欧州のGMP細胞治療用消耗品市場は、2022年の48億2,785万米ドルから2028年には205億6,916万米ドルに成長すると予測、2022年から2028年までのCAGRは27.2%と推定されます。

研究開発と創薬の増加が欧州のGMP細胞治療用消耗品市場をけん引

創薬は、早期発見、前臨床段階、臨床段階、規制当局の承認など、さまざまな段階からなる長いプロセスです。このプロセスでは、望ましい結果を得るために、細胞治療用消耗品を使用することが非常に重要です。世界保健機関（WHO）によると、2020年にはがんによる死亡者数が1,000万人に達し、最も一般的ながんの種類は乳がん、肺がん、結腸がん、直腸がん、前立腺がんです。様々な調査研究により、がん、神経疾患、自己免疫疾患、その他の慢性疾患を効果的に治療できる薬剤の良好な結果が示されています。したがって、慢性疾患の有病率の上昇は、研究開発（R&D）活動に対する需要を促進します。さらに、アミロイドーシス、アドレノリューコジストロフィー、エーラス・ダンロス症候群など、さまざまな希少疾患の発生率が高まっていることも、医薬品開発のための研究開発活動を活発化させています。

さらに、GMP細胞治療用消耗品市場で事業を展開する数多くのバイオテクノロジー企業が、世界レベルで研究開発活動を加速させるために協業しています。例えば、2022年10月、センチュリー・セラピューティクスとブリストル・マイヤーズスクイブは、血液悪性腫瘍および固形腫瘍を対象に、人工多能性幹細胞（「iPSC」）由来の、人工ナチュラルキラー細胞（「iNK」）やT細胞（「iT」）プログラムを最大4つまで開発・商業化する研究提携およびライセンス契約を発表しました。さらに、個別化医療や再生医療に対する需要の高まりが、細胞治療用消耗品市場の成長を後押ししています。このように、研究開発活動の増加や創薬の急増により、GMP細胞治療用消耗品の使用は飛躍的に増加しており、この地域全体のGMP細胞治療用消耗品市場の成長を牽引しています。

欧州のGMP細胞治療用消耗品市場の概要

欧州のGMP細胞治療用消耗品市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。この地域は、世界のGMP細胞治療用消耗品市場において大きなシェアを占めています。同地域の市場開拓は、ヘルスケア支出の増加、がん罹患率の上昇、健康意識の高まり、研究開発の活発化などに起因しています。ドイツは、欧州で最も急成長しているGMP細胞治療用消耗品市場のひとつと考えられています。GMP細胞治療用消耗品の重要性の高まりと地域プレイヤーの拡大が、ドイツでの市場成長を後押ししています。また、連邦統計局は、ドイツの医療費の増加を報告しており、これがヘルスケア分野の研究開発に役立っています。ドイツ貿易投資庁（GTAI）によると、ドイツのバイオテクノロジー産業は数年前から急速に拡大しています。平均して、710社以上の企業がバイオテクノロジー分野に従事しています。全体として、バイオテクノロジー部門の収益は36％増加し、研究開発費は37％増加しました。ドイツでは、革新的な製薬会社、医薬品メーカー、医薬品開発業務受託機関（CRO）、中小のバイオ医薬品会社の数が増加しています。

さらに、ドイツでは、細胞治療分野で目覚ましいイノベーションが起きています。例えば、2021年、ドイツの連邦ワクチン・バイオ医薬品研究所（Paul-Ehrlich-Institut）は、RHEACELLの細胞治療製品「アメサナー」について、慢性創傷を持つ患者への使用を国家承認しました。また、2022年6月には、バイエルのBlueRock Therapeuticsが、細胞療法イノベーションのための欧州サイトを設立しました。ブルーロック社は現在、パーキンソン病治療を目的とした新規細胞療法「BRT-DA01」の第I相臨床試験に取り組んでいます。政府の医療費の増加、ドイツにおける世界企業の拡大、メーカーによる製品開発の増加は、GMP細胞治療用消耗品の応用を後押ししており、欧州のGMP細胞治療用消耗品市場の成長も後押ししています。

欧州のGMP細胞治療用消耗品市場の収益と2028年までの予測（金額）

欧州のGMP細胞治療用消耗品市場のセグメンテーション

欧州のGMP細胞治療用消耗品市場は、製品、細胞療法、プロセス、エンドユース、国別に区分されます。

製品別では、GMP細胞治療用消耗品市場は、キット、試薬/分子生物学試薬、成長因子/サイトカインおよびインターロイキン（タンパク質および核酸精製バッファーを含む）、その他に分類されます。2022年の欧州のGMP細胞治療用消耗品市場では、キット部門が最大のシェアを占めています。

細胞療法に基づき、GMP細胞治療用消耗品市場は、NK細胞療法、幹細胞療法、T細胞療法、およびその他に区分されます。T細胞療法セグメントは、2022年に欧州のGMP細胞治療用消耗品市場で最大のシェアを登録しました。プロセスは、細胞収集と特性評価/選別・分離、細胞培養と拡大/調製、凍結保存、細胞加工と製剤、細胞分離と活性化、細胞分配/ハンドリング、プロセスモニタリングと制御/読み取り管理/品質保証、およびその他に分類されます。2022年の欧州のGMP細胞治療用消耗品市場では、細胞の収集と特性評価/選別・分離分野が最大のシェアを占めています。エンドユースに基づき、市場は臨床、商業、研究に区分されます。2022年の欧州のGMP細胞治療用消耗品市場では、臨床分野が最大のシェアを占めています。国別に見ると、欧州のGMP細胞治療用消耗品市場は、フランス、イタリア、ドイツ、スペイン、英国、その他欧州に区分されます。2022年の欧州のGMP細胞治療用消耗品市場はドイツが独占。Bio-Techne Corp、BPS Bioscience Inc、Corning Inc、FUJIFILM Irvine Scientific Inc、Global Life Sciences Solutions USA LLC、Lonza Group AG、Merck KGaA、Miltenyi Biotec BV &Co KG、Sartorius AG、Thermo Fisher Scientific Incが欧州の細胞治療消耗品市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 欧州のGMP細胞治療用消耗品市場- 重要なポイント

第3章 調査手法

• カバレッジ
• 2次調査
• 1次調査

第4章 欧州のGMP細胞治療用消耗品市場- 市場情勢

• 欧州PEST分析
• 専門家の見解

第5章 欧州のGMP細胞治療用消耗品市場- 主要市場力学

• 市場促進要因
  • 研究開発と創薬活動の活発化
  • 戦略的提携の増加
• 市場抑制要因
  • 厳しい規制政策
• 今後の動向
  • 臨床試験の増加、GMP需要の高まり
• 影響度分析

第6章 GMP細胞治療用消耗品市場- 欧州の分析

• 欧州のGMP細胞治療用消耗品市場の収益と予測・分析

第7章 欧州のGMP細胞治療用消耗品市場- 2028年までの収益と予測：製品別

• 欧州のGMP細胞治療用消耗品市場：製品別、売上高シェア 2021年・2028年（%）
• キット
• 試薬/分子生物学用試薬
• 成長因子／サイトカイン／インターロイキン（タンパク質・核酸精製用バッファーを含む）
• その他

第8章 欧州のGMP細胞治療用消耗品市場の分析と2028年までの予測：細胞治療分野別

• 欧州のGMP細胞治療用消耗品市場：細胞療法別、2021年・2028年（%）
• NK細胞療法
• ステムセルセラピー
• T細胞療法
• その他

第9章 欧州のGMP細胞治療用消耗品市場：エンドユース別、収益と2028年までの予測

• 欧州のGMP細胞治療用消耗品市場2021年・2028年、エンドユーザー別、売上高シェア（%）
• 臨床用
• 商業
• 調査

第10章 欧州のGMP細胞治療用消耗品市場の収益と2028年までの予測：プロセス別

• 欧州のGMP細胞治療用消耗品市場2021年・2028年エンドユーザー別売上高シェア（%）
• 細胞の収集と特性評価／選別と分離
• 細胞培養・拡大/調製
• 凍結保存
• 細胞加工・製剤化
• 細胞の単離と活性化
• 細胞流通・ハンドリング
• プロセスのモニタリングとコントロール/管理/品質保証
• その他

第11章 欧州のGMP細胞治療用消耗品市場-2028年までの収益と予測：国別分析

• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第12章 GMP細胞治療用消耗品市場- 業界情勢

• GMP細胞治療用消耗品市場の成長戦略
• 無機的成長戦略
• 有機的成長戦略

第13章 企業プロファイル

• Sartorius AG
• Thermo Fisher Scientific Inc
• Miltenyi Biotec BV & Co KG
• Bio-Techne Corp
• Corning Inc
• FUJIFILM Irvine Scientific Inc
• Lonza Group AG
• BPS Bioscience Inc
• Merck KGaA
• Global Life Sciences Solutions USA LLC

第14章 付録

List Of Tables

• Table 1. Germany GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
• Table 2. Germany GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
• Table 3. Germany GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
• Table 4. Germany GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
• Table 5. UK GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
• Table 6. UK GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
• Table 7. UK GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
• Table 8. UK GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
• Table 9. France GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
• Table 10. France GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
• Table 11. France GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
• Table 12. France GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
• Table 13. Italy GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
• Table 14. Italy GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
• Table 15. Italy GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
• Table 16. Italy GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
• Table 17. Spain GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
• Table 18. Spain GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
• Table 19. Spain GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
• Table 20. Spain GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
• Table 21. Rest of Europe GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
• Table 22. Rest of Europe GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
• Table 23. Rest of Europe GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
• Table 24. Rest of Europe GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
• Table 25. Recent Inorganic Growth Strategies in the GMP Cell Therapy Consumables Market
• Table 26. Recent Organic Growth Strategies in GMP Cell Therapy Consumables Market
• Table 27. Glossary of Terms

List Of Figures

• Figure 1. Europe GMP Cell Therapy Consumables Market Segmentation
• Figure 2. Europe GMP Cell Therapy Consumables Market, by Country
• Figure 3. Europe GMP Cell Therapy Consumables Market Overview
• Figure 4. Kits Segment Held the Largest Share of Product Segment in Europe GMP Cell Therapy Consumables Market
• Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
• Figure 6. Europe: PEST Analysis
• Figure 7. Experts' Opinion
• Figure 8. Europe GMP Cell Therapy Consumables Market: Impact Analysis of Drivers and Restraints
• Figure 9. Europe GMP Cell Therapy Consumables Market - Revenue Forecast and Analysis - 2019-2028
• Figure 10. Europe GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
• Figure 11. Kits: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 12. Reagents/ Molecular Biology Reagents: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 13. Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 14. Others: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 15. Europe GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
• Figure 16. NK Cell Therapy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 17. Stem Cell Therapy: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 18. T-cell Therapy: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 19. Other Applications: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 20. Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
• Figure 21. Clinical: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 22. Commercial: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 23. Research: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 24. Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
• Figure 25. Cell Collection and Characterization/Sorting and Separation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 26. Cell Culture and Expansion/Preparation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 27. Cryopreservation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 28. Cell Processing and Formulation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 29. Cell Isolation and Activation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 30. Cell Distribution/Handling: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 31. Process Monitoring and Control/Readministration/Quality Assurance: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 32. Other: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 33. Europe: GMP Cell Therapy Consumables Market, by Key Country - Revenue (2021) (US$ Million)
• Figure 34. Europe: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)
• Figure 35. Germany: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 36. UK: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 37. France: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 38. Italy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 39. Spain: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 40. Rest of Europe: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 41. Growth Strategies in GMP Cell Therapy Consumables Market

The Europe GMP cell therapy consumables market is expected to grow from US$ 4,827.85 million in 2022 to US$ 20,569.16 million by 2028; it is estimated to grow at a CAGR of 27.2% from 2022 to 2028.

Rise in Research & Development and Drug Discovery Drives Europe GMP Cell Therapy Consumables Market

Drug discovery is a long process that comprises various steps such as early discovery, preclinical phase, clinical phase, and regulatory approval. The process tremendously involves the use of cell therapy consumables to achieve the desired results. According to the World Health Organization, ~10 million deaths due to cancer were recorded in 2020, and the most common types of cancer are breast cancer, lung cancer, colon cancer, rectum cancer, and prostate cancer. Various research studies have shown positive outcomes of drugs that can effectively treat cancer, neurological disorders, autoimmune disorders, and other chronic disorders. Therefore, the rising prevalence of chronic disorders propels the demand for research and development(R&D) activities. In addition, the growing incidence of various rare disorders such as amyloidosis, Adrenoleukodystrophy, and Ehlers-Danlos syndrome has increased the R&D activities for drug development.

Moreover, numerous biotechnology companies operating in the GMP cell therapy consumables market are collaborating to accelerate R&D activities on a global level. For instance, in October 2022, Century Therapeutics and Bristol Myers Squibb announced the research collaboration and license agreement to develop and commercialize up to four induced pluripotent stem cells ("iPSC") derived, engineered natural killer cell ("iNK") and/or T cell ("iT") programs for hematologic malignancies and solid tumors. Additionally, the rising demand for personalized and regenerative medicine has boosted the growth of the cell therapy consumables market. Thus, an increase in research & development activities along with a surge in drug discovery has tremendously increased the use of GMP cell therapy consumables, which is driving the growth of the GMP cell therapy consumables market across the region.

Europe GMP Cell Therapy Consumables Market Overview

The Europe GMP cell therapy consumables market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global GMP cell therapy consumables market. The market growth in the region is due to increasing healthcare expenditure, rising incidence of cancer, increasing health awareness, and growing research and development. Germany is considered among the fastest-growing GMP cell therapy consumables market in Europe. The growing importance of GMP cell therapy consumables, along with the expansion of regional players, is aiding the market growth in Germany. Further, The Federal Statistical Office reported an increase in health expenditure in Germany which aids in research and development in the healthcare sector. According to German Trade and Invest (GTAI), Germany's biotech industry has been rapidly expanding for some years. On average, more than 710 companies are engaged in the biotechnology sector. Overall, the biotech sector revenue is increased by 36%, while R&D spending has increased by 37%. Germany has experienced a growth in the number of innovative pharmaceutical companies, drug manufacturers, contract research organizations (CROs), and small- and medium-sized biopharmaceutical companies.

Further, there have been remarkable innovations in the cell therapy segment in Germany. For instance, in 2021, Germany's Federal Institute for Vaccines and Biomedicines (Paul-Ehrlich-Institut) granted RHEACELL national approval for its cell therapy product-AMESANAR-for use in patients having chronic wounds. Similarly, in June 2022, Bayer's BlueRock Therapeutics established a European site for cell therapy innovation. BlueRock is currently engaged in a Phase I clinical trial for its novel cell therapy, BRT-DA01, for treating Parkinson's disease. The rising government health expenditure, growing expansion of global players in Germany, and increasing product development by manufacturers are boosting the application of GMP cell therapy consumables, which is also boosting the growth of the Europe GMP cell therapy consumables market.

Europe GMP Cell Therapy Consumables Market Revenue and Forecast to 2028 (US$ Million)

Europe GMP Cell Therapy Consumables Market Segmentation

The Europe GMP cell therapy consumables market is segmented on the basis of product, cell therapy, process, end use, and country.

Based on product, the GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest share of the Europe GMP cell therapy consumables market in 2022.

Based on cell therapy, the GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment registered the largest share of the Europe GMP cell therapy consumables market in 2022. Based on process, the market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the Europe GMP cell therapy consumables market in 2022. Based on end use, the market is segmented into clinical, commercial, and research. The clinical segment held the largest share of the Europe GMP cell therapy consumables market in 2022. Based on country, the Europe GMP cell therapy consumables market is segmented into France, Italy, Germany, Spain, the UK, and the Rest of Europe. Germany dominated the Europe GMP cell therapy consumables market in 2022. Bio-Techne Corp, BPS Bioscience Inc, Corning Inc, FUJIFILM Irvine Scientific Inc, Global Life Sciences Solutions USA LLC, Lonza Group AG, Merck KGaA, Miltenyi Biotec BV & Co KG, Sartorius AG, and Thermo Fisher Scientific Inc are the leading companies operating in the Europe cell therapy consumables market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe GMP cell therapy consumables market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe GMP cell therapy consumables market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the GMP cell therapy consumables market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

• 1.1 Study Scope
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 Europe GMP Cell Therapy Consumables Market - by Product
  • 1.3.2 Europe GMP Cell Therapy Consumables Market - by Cell Therapy
  • 1.3.3 Europe GMP Cell Therapy Consumables Market - by End Use
  • 1.3.4 Europe GMP Cell Therapy Consumables Market - by End Use
  • 1.3.5 Europe GMP Cell Therapy Consumables Market - by Country

2. Europe GMP Cell Therapy Consumables Market - Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Europe GMP Cell Therapy Consumables Market - Market Landscape

• 4.1 Overview
• 4.2 Europe PEST Analysis
• 4.3 Experts' Opinion

5. Europe GMP Cell Therapy Consumables Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Rise in Research & Development and Drug Discovery
  • 5.1.2 Increase in Strategic Collaborations
• 5.2 Market Restraints
  • 5.2.1 Stringent Regulatory Policies
• 5.3 Future Trends
  • 5.3.1 Increasing Clinical Trials and Rising GMP Demand
• 5.4 Impact Analysis

6. GMP Cell Therapy Consumables Market - Europe Analysis

• 6.1 Europe GMP Cell Therapy Consumables Market Revenue Forecast and Analysis

7. Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - by Product

• 7.1 Overview
• 7.2 Europe GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
• 7.3 Kits
  • 7.3.1 Overview
  • 7.3.2 Kits: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 7.4 Reagents/ Molecular Biology Reagents
  • 7.4.1 Overview
  • 7.4.2 Reagents/ Molecular Biology Reagents: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 7.5 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers)
  • 7.5.1 Overview
  • 7.5.2 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 7.6 Others
  • 7.6.1 Overview
  • 7.6.2 Others: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe GMP Cell Therapy Consumables Market Analysis and Forecasts to 2028 - by Cell Therapy

• 8.1 Overview
• 8.2 Europe GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
• 8.3 NK Cell Therapy
  • 8.3.1 Overview
  • 8.3.2 NK Cell Therapy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 8.4 Stem Cell Therapy
  • 8.4.1 Overview
  • 8.4.2 Stem Cell Therapy: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 8.5 T-cell Therapy
  • 8.5.1 Overview
  • 8.5.2 T-cell Therapy: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 8.6 Others
  • 8.6.1 Overview
  • 8.6.2 Others: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - by End Use

• 9.1 Overview
• 9.2 Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
• 9.3 Clinical
  • 9.3.1 Overview
  • 9.3.2 Clinical: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 9.4 Commercial
  • 9.4.1 Overview
  • 9.4.2 Commercial: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 9.5 Research
  • 9.5.1 Overview
  • 9.5.2 Research: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - by Process

• 10.1 Overview
• 10.2 Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
• 10.3 Cell Collection and Characterization/Sorting and Separation
  • 10.3.1 Overview
  • 10.3.2 Cell Collection and Characterization/ Sorting and Separation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.4 Cell Culture and Expansion/Preparation
  • 10.4.1 Overview
  • 10.4.2 Cell Culture and Expansion/Preparation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.5 Cryopreservation
  • 10.5.1 Overview
  • 10.5.2 Cryopreservation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.6 Cell Processing and Formulation
  • 10.6.1 Overview
  • 10.6.2 Cell Processing and Formulation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.7 Cell Isolation and Activation
  • 10.7.1 Overview
  • 10.7.2 Cell Isolation and Activation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.8 Cell Distribution/Handling
  • 10.8.1 Overview
  • 10.8.2 Cell Distribution/Handling: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.9 Process Monitoring and Control/Readministration/Quality Assurance
  • 10.9.1 Overview
  • 10.9.2 Process Monitoring and Control/Readministration/Quality Assurance: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.10 Other
  • 10.10.1 Overview
  • 10.10.2 Other: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)

11. Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - Country Analysis

• 11.1 Overview
  • 11.1.1 Europe: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)
    • 11.1.1.1 Germany: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.1.1 Overview
      • 11.1.1.1.2 Germany: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.1.3 Germany: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
      • 11.1.1.1.4 Germany: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
      • 11.1.1.1.5 Germany: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.1.1.6 Germany: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
    • 11.1.1.2 UK: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.2.1 Overview
      • 11.1.1.2.2 UK: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.2.3 UK: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
      • 11.1.1.2.4 UK: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
      • 11.1.1.2.5 UK: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.1.2.6 UK: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
    • 11.1.1.3 France: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.3.1 Overview
      • 11.1.1.3.2 France: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.3.3 France: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
      • 11.1.1.3.4 France: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
      • 11.1.1.3.5 France: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.1.3.6 France: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
    • 11.1.1.4 Italy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.4.1 Overview
      • 11.1.1.4.2 Italy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.4.3 Italy: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
      • 11.1.1.4.4 Italy: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
      • 11.1.1.4.5 Italy: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.1.4.6 Italy: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
    • 11.1.1.5 Spain: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.5.1 Overview
      • 11.1.1.5.2 Spain: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.5.3 Spain: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
      • 11.1.1.5.4 Spain: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
      • 11.1.1.5.5 Spain: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.1.5.6 Spain: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
    • 11.1.1.6 Rest of Europe: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.6.1 Overview
      • 11.1.1.6.2 Rest of Europe: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.6.3 Rest of Europe: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
      • 11.1.1.6.4 Rest of Europe: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
      • 11.1.1.6.5 Rest of Europe: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.1.6.6 Rest of Europe: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)

12. GMP Cell Therapy Consumables Market - Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies in GMP Cell Therapy Consumables Market
• 12.3 Inorganic Growth Strategies
  • 12.3.1 Overview
• 12.4 Organic Growth Strategies
  • 12.4.1 Overview

13. Company Profiles

• 13.1 Sartorius AG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Thermo Fisher Scientific Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Miltenyi Biotec BV & Co KG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 Bio-Techne Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 Corning Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 FUJIFILM Irvine Scientific Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 Lonza Group AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
• 13.8 BPS Bioscience Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
• 13.9 Merck KGaA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
• 13.10 Global Life Sciences Solutions USA LLC
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

• 14.1 About The Insight Partners
• 14.2 Glossary of Terms